Aliases & Classifications for Diabetic Macular Edema

About this section

Aliases & Descriptions for Diabetic Macular Edema:

Name: Diabetic Macular Edema 8 10 44 61


External Ids:

Disease Ontology8 DOID:9191
SNOMED-CT56 312912001
ICD9CM27 362.07

Summaries for Diabetic Macular Edema

About this section
MalaCards based summary: Diabetic Macular Edema is related to retinal vein occlusion and retinal detachment. An important gene associated with Diabetic Macular Edema is SERPINF1 (serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1), and among its related pathways are Immune response Oncostatin M signaling via JAK Stat in human cells and LDL Oxidation in Atherogenesis. The compounds olmesartan and perindopril have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and retina, and related mouse phenotypes are tumorigenesis and endocrine/exocrine gland.

Related Diseases for Diabetic Macular Edema

About this section

Diseases related to Diabetic Macular Edema via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 130)
idRelated DiseaseScoreTop Affiliating Genes
1retinal vein occlusion31.5VEGFA
2retinal detachment31.3VEGFA, SERPINF1
3blindness30.4INS, VEGFA, SERPINF1, PRKCB, AKR1B1
4neuropathy30.3SOD2, AKR1B1, INS
5ischemia30.0VEGFA, ICAM1, FGF2, NOS3, SOD2, AKR1B1
6retinitis11.1
7endotheliitis10.9
8cataract10.7
9central retinal vein occlusion10.6VEGFA
10vitreous detachment10.6
11dengue shock syndrome10.6THBD
12diabetic autonomic neuropathy10.6AKR1B1
13hypoaldosteronism10.6REN
14gitelman syndrome10.6REN
15exudative vitreoretinopathy 110.5VEGFA
16malaria10.5ICAM1
17diabetic cataract10.5AKR1B1
18angiodysplasia10.5SST
19dumping syndrome10.5SST
20leukostasis10.5ICAM1
21rheumatoid vasculitis10.5ICAM1
22classic kaposi sarcoma10.4IL6
23zollinger-ellison syndrome10.4SST
24meningioma, familial10.4SST
25macular retinal edema10.4VEGFA, SERPINF1, PRKCB
26ovarian hyperstimulation syndrome10.4REN, VEGFA
27ocular hypotension10.3
28sleep disorder10.3
29poems syndrome10.3IL6, VEGFA
30allergic contact dermatitis10.3ICAM1, DYT10
31vascular cancer10.3VEGFA, FGF2
32pure autonomic failure10.3EPO, REN
33hypoglycemic coma10.3INS
34retinal vascular disease10.3DYT10, SERPINF1, VEGFA, AKR1B1
35corneal neovascularization10.3VEGFA, FGF2, SERPINF1
36hemangioblastoma10.3EPO, VEGFA
37peripheral vascular disease10.3INS
38glomerulosclerosis10.2CCL2, REN, AKR1B1
39retinal degeneration10.2FGF2, AKR1B1, SERPINF1
40lung cancer susceptibility 310.2THBD, VEGFA, SOD2, DYT10
41myelofibrosis10.2EPO, FGF2
42factor vii deficiency10.2VEGFA, SST, FGF2
43impotence10.2DYT10, NOS3
44uveitis10.2SERPINF1, CCL2, ICAM1
45burns10.2
46ischemic optic neuropathy10.2
47macular holes10.2
48choroiditis10.2
49hypoxia10.2
50acute erythroid leukemia10.2PRKCB, DYT10, EPO

Graphical network of the top 20 diseases related to Diabetic Macular Edema:



Diseases related to diabetic macular edema

Symptoms for Diabetic Macular Edema

About this section

Drugs & Therapeutics for Diabetic Macular Edema

About this section

Drug clinical trials:

Search ClinicalTrials for Diabetic Macular Edema

Search NIH Clinical Center for Diabetic Macular Edema

Genetic Tests for Diabetic Macular Edema

About this section

Anatomical Context for Diabetic Macular Edema

About this section

MalaCards organs/tissues related to Diabetic Macular Edema:

31
Eye, Endothelial, Retina, Testes

Animal Models for Diabetic Macular Edema or affiliated genes

About this section

MGI Mouse Phenotypes related to Diabetic Macular Edema:

35 (show all 21)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.2SOD2, ICAM1, CCL2, IL6, FGF2, VEGFA
2MP:00053798.1INS, VEGFA, ICAM1, IL6, NOS3, SERPINF1
3MP:00053757.9NOS3, CCL2, SOD2, IL6, INS
4MP:00053677.9NOS3, REN, VEGFA, INS, THBD, SOD2
5MP:00028737.8NOS3, CCL2, SST, REN, EPO, VEGFA
6MP:00053707.7INS, IL6, NOS3, CCL2, EPO, VEGFA
7MP:00053897.7THBD, INS, NOS3, VEGFA, REN, SERPINF1
8MP:00107717.7SOD2, VEGFA, EPO, INS, CCL2, ICAM1
9MP:00053907.5AKR1B1, IL6, INS, FGF2, NOS3, VEGFA
10MP:00053817.5NOS3, IL6, CCL2, SST, ICAM1, SERPINF1
11MP:00053697.3REN, ICAM1, CCL2, VEGFA, FGF2, NOS3
12MP:00053917.1ICAM1, SOD2, INS, FGF2, NOS3, IL6
13MP:00053876.9ICAM1, VEGFA, SOD2, PRKCB, REN, CCL2
14MP:00053846.8CCL2, INS, THBD, EPO, ICAM1, SOD2
15MP:00053786.8VEGFA, INS, THBD, AKR1B1, REN, ICAM1
16MP:00053976.5EPO, REN, THBD, INS, SOD2, VEGFA
17MP:00107686.4NOS3, CCL2, THBD, INS, EPO, AKR1B1
18MP:00053866.3PRKCB, SOD2, VEGFA, AKR1B1, SST, FGF2
19MP:00036316.3CCL2, SST, ICAM1, IL6, FGF2, NOS3
20MP:00053856.3CCL2, SOD2, IL6, FGF2, THBD, VEGFA
21MP:00053766.0REN, SOD2, EPO, PRKCB, AKR1B1, CCL2

Publications for Diabetic Macular Edema

About this section

Articles related to Diabetic Macular Edema:

(show top 50)    (show all 551)
idTitleAuthorsYear
1
Recent advances in management of diabetic macular edema. (25801496)
2015
2
SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety. (25719988)
2015
3
Correlation Between Visual Function and Photoreceptor Integrity in Diabetic Macular Edema: Spectral-Domain Optical Coherence Tomography. (25897822)
2015
4
Intraretinal fibrosis in exudative diabetic macular edema after ranibizumab treatments. (25372542)
2014
5
Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema. (23334618)
2013
6
Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema. (24379923)
2013
7
Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab. (24263379)
2013
8
Development of a Semi-Automatic Segmentation Method for Retinal OCT Images Tested in Patients with Diabetic Macular Edema. (24386127)
2013
9
NAVILAS Laser System Focal Laser Treatment for Diabetic Macular Edema - One Year Results of a Case Series. (24082979)
2013
10
Risk factors associated with diabetic macular edema. (23380134)
2013
11
Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema. (23347793)
2013
12
Paired responses to intravitreal bevacizumab in diabetic macular edema: predictors of response in the fellow eye. (23873254)
2013
13
Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular edema and its correlation with anti-VEGF treatment outcomes. (23927080)
2013
14
Diabetic macular edema: Current management 2013. (24379911)
2013
15
Subtenon injection of natural leukocyte interferon I+-2a in diabetic macular edema: a case report. (24165224)
2013
16
Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy. (22677359)
2013
17
Diabetic macular edema: New promising therapies. (24379924)
2013
18
Ranibizumab injection for diabetic macular edema: meta-analysis of systemic safety and systematic review. (23931473)
2013
19
Classification of diabetic retinopathy and diabetic macular edema. (24379919)
2013
20
Intravitreal bevacizumab may increase diabetic macular edema in eyes with attached posterior vitreous. (23467022)
2013
21
Structural changes in individual retinal layers in diabetic macular edema. (24073417)
2013
22
Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema. (23730111)
2013
23
Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. (22234244)
2012
24
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. (22727177)
2012
25
Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study. (22589436)
2012
26
Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study). (23074206)
2012
27
Evaluation of a Novel, Non Contact, Automated Focal Laser with Integrated (NAVILAS) Fluorescein Angiography for Diabetic Macular Edema. (22346133)
2012
28
Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation. (21780926)
2011
29
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema. (21836404)
2011
30
Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. (21631366)
2011
31
Imaging of diabetic retinopathy and diabetic macular edema. (21607565)
2011
32
Targeting the pathophysiology of diabetic macular edema. (20980428)
2010
33
Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. (20079541)
2010
34
Pattern electroretinogram changes after intravitreal bevacizumab injection for diabetic macular edema. (20140695)
2010
35
Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. (19996821)
2010
36
Polyunsaturated Fatty Acid Composition of Surgically Removed Hard Exudates in Diabetic Macular Edema. (20337342)
2010
37
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. (20212197)
2010
38
Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema. (19568355)
2009
39
Diabetic macular edema. (23960851)
2009
40
Update on laser treatment of diabetic macular edema. (19349789)
2009
41
Intravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema. (19954371)
2009
42
Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular edema. (19294405)
2009
43
Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema. (18708615)
2009
44
Diabetic macular edema. (19729104)
2009
45
The article by Kook et al 1 on the 1-year effect of bevacizumab in patients with chronic diffuse diabetic macular edema (DME). (19430285)
2009
46
Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study. (19357559)
2009
47
Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. (18327133)
2008
48
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. (19027427)
2008
49
Vitreous surgery for diabetic macular edema--its prognosis and correlation between preoperative systemic and ocular conditions and visual outcome. (18025629)
2007
50
Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. (13129863)
2003

Variations for Diabetic Macular Edema

About this section

Expression for genes affiliated with Diabetic Macular Edema

About this section
Search GEO for disease gene expression data for Diabetic Macular Edema.

Pathways for genes affiliated with Diabetic Macular Edema

About this section

Pathways related to Diabetic Macular Edema according to GeneCards Suite gene sharing:

(show all 30)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.9CCL2, VEGFA
29.8ICAM1, CCL2
3
Show member pathways
Angiogenesis36
9.4VEGFA, FGF2, NOS3
49.3SST, VEGFA, IL6
59.3REN, FGF2, NOS3
6
Show member pathways
9.3NOS3, PRKCB, VEGFA, THBD
79.3IL6, ICAM1, PRKCB
89.3NOS3, INS, PRKCB
9
Show member pathways
9.2VEGFA, FGF2, NOS3, PRKCB
109.1ICAM1, CCL2, IL6
119.1ICAM1, CCL2, IL6
129.1IL6, CCL2, ICAM1
13
Show member pathways
Signaling Pathways in Glioblastoma36
9.1INS, VEGFA, PRKCB, FGF2
14
Show member pathways
9.1PRKCB, VEGFA, INS, FGF2
15
Show member pathways
IL-9 Signaling Pathway36
Development Thrombopoietin regulated cell processes59
IL-7 Signaling Pathway36
Immune response IL 9 signaling pathway59
9.1PRKCB, IL6, INS
16
Show member pathways
PLK2 and PLK4 events36
Polo-like kinase signaling events in the cell cycle36
9.0INS, SOD2, IL6
17
Show member pathways
9.0IL6, EPO, SOD2, VEGFA
189.0VEGFA, IL6, FGF2, PRKCB
198.9VEGFA, IL6, CCL2, ICAM1
20
Show member pathways
8.9PRKCB, IL6, ICAM1, CCL2
21
Show member pathways
Development VEGF signaling via VEGFR2 generic cascades59
8.9VEGFA, PRKCB, NOS3, CCL2, ICAM1
228.8IL6, CCL2, NOS3, THBD
23
Show member pathways
IL23-mediated signaling events36
Immune response IL 10 signaling pathway59
Angiopoietin receptor Tie2-mediated signaling36
Development PDGF signaling via STATs and NF kB59
Development Angiopoietin Tie2 signaling59
8.6FGF2, NOS3, CCL2, IL6
24
Show member pathways
thioredoxin pathway36
8.3CCL2, SOD2, INS, ICAM1, IL6
25
Show member pathways
8.3INS, CCL2, IL6, FGF2, REN
26
Show member pathways
8.2CCL2, EPO, INS, IL6, FGF2
278.1PRKCB, INS, VEGFA, IL6, EPO, NOS3
287.9NOS3, FGF2, INS, VEGFA, EPO, IL6
29
Show member pathways
7.5SOD2, NOS3, IL6, CCL2, EPO, VEGFA

Compounds for genes affiliated with Diabetic Macular Edema

About this section

Compounds related to Diabetic Macular Edema according to GeneCards Suite gene sharing:

(show top 50)    (show all 224)
idCompoundScoreTop Affiliating Genes
1olmesartan44 28 1111.5INS, CCL2, REN, SERPINF1
2perindopril44 50 1111.5NOS3, REN, VEGFA, THBD
3aminoguanidine44 28 1111.4AKR1B1, SOD2, NOS3, EPO
4streptozotocin449.1INS, SERPINF1, SST, NOS3, AKR1B1
5gm-csf44 2810.0EPO, ICAM1, CCL2, IL6, VEGFA
6cyclophosphamide44 50 1110.9NOS3, THBD, VEGFA, SOD2, SST, CCL2
7bleomycin44 119.8FGF2, NOS3, CCL2, EPO, SOD2
8thalidomide44 50 60 1111.8EPO, FGF2, IL6, VEGFA, THBD
9ang ii448.7NOS3, DYT10, CCL2, REN, VEGFA
10fluvastatin44 50 28 1111.7IL6, NOS3, CCL2, THBD, ICAM1
11nadph44 249.7THBD, SERPINF1, SOD2, PRKCB, CCL2, NOS3
1215-deoxy-delta-12,14-prostaglandin j2448.7CCL2, NOS3, FGF2, IL6, VEGFA
13atorvastatin44 50 28 24 1112.6NOS3, IL6, THBD, VEGFA, CCL2, ICAM1
14prostacyclin448.6CCL2, ICAM1, NOS3, REN, FGF2, VEGFA
15curcumin448.6THBD, IL6, AKR1B1, VEGFA, ICAM1, CCL2
16ascorbic acid44 249.6EPO, THBD, NOS3, SOD2, AKR1B1, FGF2
17simvastatin44 50 60 28 24 1113.5THBD, VEGFA, ICAM1, CCL2, IL6, NOS3
18calcitriol44 60 24 1111.5PRKCB, SOD2, THBD, IL6, EPO, REN
19fenofibrate44 50 1110.5NOS3, INS, IL6, ICAM1, CCL2
20gf 109203x44 609.5PRKCB, VEGFA, DYT10, FGF2, SOD2, NOS3
21polymyxin b448.5IL6, THBD, DYT10, CCL2, ICAM1
22hydrocortisone44 1 60 1111.4EPO, REN, INS, FGF2, IL6, SST
238-isoprostane448.3THBD, ICAM1, IL6, CCL2, NOS3, INS
24pravastatin44 50 28 24 1112.3CCL2, NOS3, IL6, ICAM1, THBD
25vitamin d448.3THBD, SOD2, EPO, IL6, PRKCB, CCL2
26matrigel448.3NOS3, THBD, ICAM1, FGF2, SERPINF1, VEGFA
27pdtc448.3SOD2, ICAM1, CCL2, IL6, DYT10
28epinephrine44 24 1110.2INS, SOD2, AKR1B1, REN, SST, IL6
29diphenyleneiodonium448.2SOD2, ICAM1, CCL2, VEGFA, DYT10, SERPINF1
30norepinephrine44 24 1110.2REN, AKR1B1, SOD2, INS, SST, CCL2
31cyclosporin a44 28 6010.2SOD2, THBD, ICAM1, PRKCB, IL6, AKR1B1
32gnrh448.1DYT10, CCL2, SST, PRKCB, EPO, INS
33lactate448.0THBD, AKR1B1, EPO, SOD2, INS, ICAM1
34arginine447.8INS, SOD2, AKR1B1, REN, SST, NOS3
35nitric oxide44 24 119.8CCL2, REN, IL6, PRKCB, SOD2, THBD
36n acetylcysteine447.8CCL2, ICAM1, AKR1B1, SERPINF1, SOD2, IL6
37creatinine447.8INS, AKR1B1, EPO, IL6, CCL2, REN
38h2o2447.8FGF2, SERPINF1, SOD2, THBD, AKR1B1, ICAM1
39glucose447.8SERPINF1, IL6, CCL2, THBD, INS, PRKCB
40sb 20358044 608.6VEGFA, FGF2, NOS3, DYT10, IL6, CCL2
41retinoic acid44 248.1THBD, SERPINF1, PRKCB, ICAM1, SST, DYT10
42dexamethasone44 50 28 1110.1FGF2, THBD, INS, IL6, CCL2, SST
43pge2447.1AKR1B1, REN, ICAM1, SST, VEGFA, IL6
44cycloheximide447.0VEGFA, THBD, SOD2, AKR1B1, ICAM1, SST
45phosphatidylinositol447.0NOS3, INS, EPO, PRKCB, ICAM1, CCL2
46actinomycin d446.9CCL2, IL6, DYT10, NOS3, FGF2, ICAM1
47genistein44 28 60 1 24 1111.9CCL2, VEGFA, SST, SOD2, NOS3, AKR1B1
48tyrosine446.6VEGFA, FGF2, DYT10, IL6, ICAM1, PRKCB
49ly294002446.6DYT10, ICAM1, INS, VEGFA, SOD2, EPO
50vegf445.6VEGFA, THBD, SERPINF1, EPO, DYT10, NOS3

GO Terms for genes affiliated with Diabetic Macular Edema

About this section

Cellular components related to Diabetic Macular Edema according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055767.2VEGFA, SERPINF1, EPO, REN, SST, CCL2
2extracellular spaceGO:00056156.1FGF2, THBD, INS, VEGFA, SERPINF1, EPO

Biological processes related to Diabetic Macular Edema according to GeneCards Suite gene sharing:

(show all 37)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of vascular endothelial growth factor receptor signaling pathwayGO:003094910.2PRKCB, VEGFA
2C21-steroid hormone biosynthetic processGO:000670010.1FGF2, AKR1B1
3kidney developmentGO:000182210.1SERPINF1, REN, VEGFA
4response to hyperoxiaGO:005509310.1EPO, SOD2
5negative regulation of platelet activationGO:001054410.0NOS3, THBD
6cell migration involved in sprouting angiogenesisGO:000204210.0VEGFA, FGF2
7positive regulation of protein autophosphorylationGO:00319549.9INS, VEGFA
8negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stressGO:019021769.9INS, SOD2
9positive regulation of blood vessel endothelial cell migrationGO:00435369.9VEGFA, FGF2
10negative regulation of calcium ion transportGO:00519269.9ICAM1, NOS3
11cellular response to hypoxiaGO:00714569.9VEGFA, EPO, ICAM1
12response to axon injuryGO:00486789.8SOD2, EPO, FGF2
13regulation of vascular endothelial growth factor productionGO:00105749.8CCL2, IL6
14positive regulation of endothelial cell proliferationGO:00019389.8FGF2, CCL2, VEGFA
15regulation of blood pressureGO:00082179.8SOD2, REN, NOS3
16lung developmentGO:00303249.7NOS3, VEGFA, FGF2
17response to electrical stimulusGO:00516029.6IL6, EPO, SOD2
18negative regulation of gluconeogenesisGO:00457219.6INS, IL6
19response to glucocorticoidGO:00513849.6CCL2, SERPINF1, IL6
20monocyte chemotaxisGO:00025489.6IL6, CCL2
21vascular endothelial growth factor receptor signaling pathwayGO:00480109.6CCL2, VEGFA
22positive regulation of angiogenesisGO:00457669.6NOS3, VEGFA, PRKCB, FGF2
23response to hypoxiaGO:00016669.5CCL2, VEGFA, SOD2
24regulation of angiogenesisGO:00457659.4IL6, FGF2
25positive regulation of DNA replicationGO:00457409.4INS, EPO, IL6
26agingGO:00075689.3CCL2, IL6, EPO, SERPINF1
27blood coagulationGO:00075969.3THBD, NOS3, VEGFA, PRKCB
28regulation of cell shapeGO:00083609.3IL6, CCL2, VEGFA, ICAM1
29response to amino acidGO:00432009.3ICAM1, IL6, CCL2, SST
30positive regulation of peptidyl-tyrosine phosphorylationGO:00507319.2INS, IL6, ICAM1, VEGFA
31positive regulation of NF-kappaB transcription factor activityGO:00510929.1IL6, ICAM1, PRKCB, INS
32response to lipopolysaccharideGO:00324969.1SOD2, REN, IL6, THBD, EPO
33response to heatGO:00094089.1CCL2, NOS3, SST, IL6
34positive regulation of nitric oxide biosynthetic processGO:00454299.1ICAM1, SOD2, IL6, INS
35response to drugGO:00424938.9SST, IL6, CCL2, ICAM1, SOD2
36negative regulation of cell proliferationGO:00082858.8SOD2, FGF2, NOS3, SST, IL6
37positive regulation of cell proliferationGO:00082848.7FGF2, INS, IL6, EPO, VEGFA

Molecular functions related to Diabetic Macular Edema according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1chemoattractant activityGO:00420569.8VEGFA, FGF2
2insulin-like growth factor receptor bindingGO:00051599.8REN, INS
3heparin bindingGO:00082019.5FGF2, CCL2, VEGFA
4hormone activityGO:00051799.4INS, EPO, SST
5cytokine activityGO:00051259.2FGF2, IL6, VEGFA
6growth factor activityGO:00080838.9FGF2, IL6, VEGFA
7protein bindingGO:00055156.5FGF2, THBD, INS, VEGFA, EPO, PRKCB

Sources for Diabetic Macular Edema

About this section
2CDC
12ExPASy
13FDA
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet